[The effect of progesterone uterine therapeutic system on dysmenorrhoea: prostaglandin F2alpha levels in menstrual blood (author's transl)]. 1978

H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt

The menstrual flow of five dysmenorrhoeic women was collected, four cycles with and two cycles without local intrauterine administration of progesterone (Progestasert). The menstrual flow of three eumenorrhoeic women served as control. Menstrual blood was collected by tampons stored in butyl-alcohol saturated with water. Prostaglandin F2alpha (PGF2alpha) was measured after purification and extraction by radioimmunoassay. The PGF2alpha production rate and concentration per ml of menstrual blood from dysmenorrhoeic women differed significantly from those of eumenorrhoeic women. In the treated cycles the PGF2alpha levels were significantly decreased (2 alpha less than or equal to 0,01), corresponding to eumenorrhoeic levels. These values were in accordance with the clinical results and indicate that uterine PG-synthesis is under progesterone control.

UI MeSH Term Description Entries
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D004412 Dysmenorrhea Painful menstruation. Menstruation, Painful,Pain, Menstrual,Dysmenorrheas,Menstrual Pain,Menstrual Pains,Menstruations, Painful,Painful Menstruation,Painful Menstruations,Pains, Menstrual
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
January 1974, Archiv fur Gynakologie,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
June 1977, Geburtshilfe und Frauenheilkunde,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
September 1978, The Journal of reproductive medicine,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
January 1974, Respiration; international review of thoracic diseases,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
April 1981, Acta obstetrica et gynaecologica Japonica,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
April 1978, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
May 1976, Akusherstvo i ginekologiia,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
April 1972, Prostaglandins,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
July 1975, Journal of animal science,
H P Zahradnik, and E Stengele, and E Kraut, and G Scharpf, and M Breckwoldt
July 1979, Prostaglandins,
Copied contents to your clipboard!